Bristol-Myers Squibb Co
SWB:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
SWB:BRM
|
US |
|
U
|
US Neurosurgical Holdings Inc
OTC:USNU
|
US |
|
Scatec ASA
OTC:STECF
|
NO |
|
General Dynamics Corp
NYSE:GD
|
US |
|
Texas Instruments Inc
NASDAQ:TXN
|
US |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 53.787 EUR with a low forecast of 28.465 EUR and a high forecast of 67.053 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
53.787
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 53.787 EUR with a low forecast of 28.465 EUR and a high forecast of 67.053 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.
